CARGO Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 98.15 million compared to USD 40.95 million a year ago. Basic loss per share from continuing operations was USD 16.53 compared to USD 104.4 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.72 USD | -2.68% | -6.90% | -27.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.78% | 658M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- CRGX Stock
- News CARGO Therapeutics, Inc.
- CARGO Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023